Press Releases

Date Title and Summary Additional Formats
Toggle Summary Harvard Bioscience Schedules Fourth Quarter 2016 Conference Call for March 9 at 4:30 PM ET
HOLLISTON, Mass., Feb. 23, 2017 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq:HBIO), a global developer, manufacturer and marketer of a broad range of solutions to advance life science, will announce results for its fourth quarter 2016 after market trading hours on Thursday, March 9, 2017.
View HTML
Toggle Summary Harvard Bioscience Reports Third Quarter 2016 Financial Results
Announces the Disposition of AHN Biotechnologie GmbH for $1.7 million
View HTML
Toggle Summary Harvard Bioscience Schedules Third Quarter 2016 Conference Call for October 27 at 4:30 PM ET
HOLLISTON, Mass., Oct. 13, 2016 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq:HBIO), a global developer, manufacturer and marketer of a broad range of solutions to advance life science, will announce results for its third quarter 2016 after market trading hours on Thursday, October 27, 2016.
View HTML
Toggle Summary Harvard Bioscience Reports Second Quarter 2016 Financial Results
Conference Call To Be Held at 8:30 AM ET Today
View HTML
Toggle Summary Harvard Bioscience Schedules Second Quarter 2016 Conference Call for July 28 at 8:30 AM ET
HOLLISTON, Mass., July 18, 2016 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq:HBIO), a global developer, manufacturer and marketer of a broad range of solutions to advance life science, will announce results for its second quarter 2016 before market trading hours on Thursday, July 28, 2016.
View HTML
Toggle Summary Harvard Bioscience to Attend The Benchmark Company, LLC One-on-One Conference in Milwaukee, Wisconsin on June 2, 2016
HOLLISTON, Mass., May 31, 2016 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (NASDAQ:HBIO), a global developer, manufacturer and marketer of a broad range of solutions to advance life science, will participate in The Benchmark Company, LLC One-on-One Conference at The Pfister Hotel in Milwaukee,
View HTML
Toggle Summary Harvard Bioscience Reports First Quarter 2016 Financial Results
Conference Call To Be Held at 8:30 AM ET Today
View HTML
Toggle Summary Harvard Bioscience Regains Compliance with NASDAQ's Continued Listing Requirements
HOLLISTON, Mass., May 04, 2016 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq:HBIO) (the "Company"), a global developer, manufacturer and marketer of a broad range of solutions to advance life science, announced today that it received written notification from NASDAQ (the "Notice") stating
View HTML
Toggle Summary Harvard Bioscience Reports Fourth Quarter and Year-End 2015 Results, Preliminary First Quarter 2016 Revenues and 2016 Financial Guidance
Reports Results of Embezzlement Investigation Conference Call to Discuss 2015 and First Quarter 2016 Results to be Held on May 12, 2016 at 8:30 AM ET HOLLISTON, Mass., April 29, 2016 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq:HBIO) (the "Company"), a global developer, manufacturer and
View HTML
Toggle Summary Harvard Bioscience Delays Filing of Annual Report on Form 10-K and Announces Preliminary Unaudited Fourth Quarter and Fiscal Year 2015 Revenue
HOLLISTON, Mass., March 28, 2016 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq:HBIO) (the "Company"), a global developer, manufacturer and marketer of a broad range of solutions to advance life science, today announced that the filing of its Annual Report on Form 10-K for the year ended
View HTML